Hybrid On November 29th Masakazu Kobayashi (Head of Assay Development and Screening Group) participated in a Cytiva™ Analytical Workshop in Tokyo, Japan. He presented a case study entitled: ‘Use of multiple biophysical assays to interrogate hit tractability in early drug discovery‘. The Cytiva™ Analytical Workshop (CAWS) originally started in 2014 with the theme of the…

Fulltime

In person Starting from Sunday October 23rd the ZoBio team participated in the 30th Protein Structure Determination in Industry meeting. On Tuesday October 25th our colleague Eiso AB gave the presentation ‘Interrogating covalent ligand protein complexes by NMR‘, which was very positively received. It was great to reconnect with the structural biology community in person. Conference…

In person Jan Schultz (Managing Director BD) has participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging…